HROW HARROW INC
2026Q1 · CUSIP 415858109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
216
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
102
Δ whales
+2
Inst. holding value
$754M
New positions
44
Closed positions
43
Price momentum (1Q)
-38.9%
Put / Call
3/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 8% | +26.1% | -23.4% |
| 2024Q3 | Top 4% | -23.8% | -32.2% |
| 2023Q3 | Top 9% | +33.6% | +95.2% |
| 2023Q1 | Top 8% | -21.9% | -62.5% |
| 2022Q2 | Top 15% | +41.3% | +120.8% |
| 2019Q1 | Top 3% | — | — |
Options Sentiment
Put holders
3
QoQ: -1
Call holders
6
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.38
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+26.2%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)